%0 Journal Article
%T Extensively Drug-Resistant Pseudomonas aeruginosa ST309 Harboring Tandem Guiana Extended Spectrum ¦Â-Lactamase Enzymes: A Newly Emerging Threat in the United States
%A An Q Dinh
%A Audrey Wanger
%A Ayesha Khan
%A Blake Hanson
%A Cesar A Arias
%A Lorena Diaz
%A Luis Ostrosky-Zeichner
%A Rafael Rios
%A Timothy Palzkill
%A Truc T Tran
%A William C Shropshire
%A William R Miller
%A Zhizeng Sun
%J Archive of "Open Forum Infectious Diseases".
%D 2019
%R 10.1093/ofid/ofz273
%X Treatment of serious infections due to multidrug-resistant (MDR) Pseudomonas aeruginosa remains a challenge, despite the introduction of novel therapeutics. In this study, we report 2 extensively drug-resistant clinical isolates of sequence type (ST) 309 P aeruginosa resistant to all ¦Â-lactams, including the novel combinations ceftolozane/tazobactam, ceftazidime/avibactam, and meropenem/vaborbactam
%K carbapenem-resistant Pseudomonas aeruginosa
%K ceftolozane/tazobactam
%K combination therapy
%K GES beta-lactamase
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602888/